Mazur E M, Wittels E G, Schiffman F J, South K, Horner R J
Cancer. 1986 Jan 1;57(1):92-9. doi: 10.1002/1097-0142(19860101)57:1<92::aid-cncr2820570119>3.0.co;2-v.
Hand mirror cell (HMC) lymphoid leukemia is an unusual variant of acute lymphocytic leukemia (ALL) in which the bone marrow lymphoblasts manifest distinctive hand mirror morphologic features. Reported here is a 66-year-old woman with HMC lymphoid leukemia whose clinical course was characterized by 12 months of initial disease stability while she was receiving no chemotherapy; a prompt response to cyclophosphamide, vincristine, and prednisone therapy once instituted; and a hyperleukocytic episode (leukocyte count 607,000/mm3), which resulted in her death after 22 months of disease. This patient and 13 other reported adults (15 years and older) with HMC lymphoid leukemia (greater than 40% bone marrow HMC) are reviewed. HMC lymphoid leukemia appears to differ from typical adult ALL in that it has a female predominance, a relatively indolent early clinical course that lasts 1 year or longer, and it manifests the possibility of survival for 1 or 2 years despite the failure to achieve a complete remission with chemotherapy. Phenotypically, the HMC leukemic cells from all adults evaluated were null cells, Ia-positive, TdT-positive, and stained positively with acid phosphates, which suggests that HMC lymphoid leukemia is a variant of non-T, non-B-ALL. HMC lymphoid leukemia in adults appears to be a distinctive clinicopathologic entity.
手镜细胞(HMC)淋巴样白血病是急性淋巴细胞白血病(ALL)的一种不寻常变体,其中骨髓原始淋巴细胞表现出独特的手镜形态特征。本文报道了一名66岁患有HMC淋巴样白血病的女性,其临床病程特点为:在未接受化疗的情况下,疾病初期稳定12个月;开始使用环磷酰胺、长春新碱和泼尼松治疗后迅速起效;以及发生高白细胞血症(白细胞计数607,000/mm³),导致其在患病22个月后死亡。对该患者以及其他13例已报道的成年(15岁及以上)HMC淋巴样白血病患者(骨髓HMC大于40%)进行了回顾。HMC淋巴样白血病似乎与典型的成人ALL不同,其特点为女性居多,早期临床病程相对惰性,持续1年或更长时间,并且尽管化疗未能达到完全缓解,但仍有存活1年或2年的可能性。从表型上看,所有接受评估的成年患者的HMC白血病细胞均为裸细胞,Ia阳性,TdT阳性,且酸性磷酸酶染色呈阳性,这表明HMC淋巴样白血病是非T、非B-ALL的一种变体。成人HMC淋巴样白血病似乎是一种独特的临床病理实体。